BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16764012)

  • 1. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
    Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
    Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free fetal DNA levels in pregnancies conceived by IVF.
    Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
    Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
    Bellver J; Lara C; Soares SR; Ramírez A; Pellicer A; Remohí J; Serra V
    Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies.
    Maymon R; Shulman A
    Prenat Diagn; 2004 Feb; 24(2):125-9. PubMed ID: 14974121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
    Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
    Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
    Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
    Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection.
    Hui PW; Lam YH; Tang MH; NG EH; Yeung WS; Ho PC
    Prenat Diagn; 2005 May; 25(5):390-3. PubMed ID: 15906430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.